These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 9826983)

  • 1. Traditional pharmacological treatments for spasticity. Part I: Local treatments.
    Gracies JM; Elovic E; McGuire J; Simpson DM
    Muscle Nerve Suppl; 1997; 6():S61-91. PubMed ID: 9826983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Traditional pharmacological treatments for spasticity. Part II: General and regional treatments.
    Gracies JM; Nance P; Elovic E; McGuire J; Simpson DM
    Muscle Nerve Suppl; 1997; 6():S92-120. PubMed ID: 9826984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injectable neuromuscular blockade in the treatment of spasticity and movement disorders.
    Tilton AH
    J Child Neurol; 2003 Sep; 18 Suppl 1():S50-66. PubMed ID: 13677571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin type A or selective neurotomy for treating focal spastic muscle overactivity?
    Deltombe T; Lejeune T; Gustin T
    Ann Phys Rehabil Med; 2019 Jul; 62(4):220-224. PubMed ID: 30107243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of ondansetron as an adjunct to lidocaine intravenous regional anesthesia on tourniquet pain and postoperative pain in patients undergoing elective hand surgery: a systematic review protocol.
    Badeaux J; Bonanno L; Au H
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):27-38. PubMed ID: 26447005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin in the management of spasticity in adults.
    Turner-Stokes L; Ward A
    Clin Med (Lond); 2002; 2(2):128-30. PubMed ID: 11991094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin.
    Koman LA; Paterson Smith B; Balkrishnan R
    Paediatr Drugs; 2003; 5(1):11-23. PubMed ID: 12513103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of action of phenol block and botulinus toxin Type A in relieving spasticity: electrophysiologic investigation and follow-up.
    On AY; Kirazli Y; Kismali B; Aksit R
    Am J Phys Med Rehabil; 1999; 78(4):344-9. PubMed ID: 10418840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.
    Sheean G
    Drug Saf; 2006; 29(1):31-48. PubMed ID: 16454533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosing, administration, and a treatment algorithm for use of botulinum toxin A for adult-onset spasticity. Spasticity Study Group.
    Brin MF
    Muscle Nerve Suppl; 1997; 6():S208-20. PubMed ID: 9826992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group].
    Wissel J; Müller J; Heinen F; Mall V; Sojer M; Ebersbach G; Poewe W
    Wien Klin Wochenschr; 1999 Oct; 111(20):837-42. PubMed ID: 10586488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interest of peripheral anesthetic blocks as a diagnosis and prognosis tool in patients with spastic equinus foot: a clinical and electrophysiological study of the effects of block of nerve branches to the triceps surae muscle.
    Buffenoir K; Decq P; Lefaucheur JP
    Clin Neurophysiol; 2005 Jul; 116(7):1596-600. PubMed ID: 15905125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alcohol neurolytic blocks for pain and muscle spasticity].
    Viel E; Pelissier J; Pellas F; Boulay C; Eledjam JJ
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):256-62. PubMed ID: 12746700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients.
    Pullman SL; Greene P; Fahn S; Pedersen SF
    Arch Neurol; 1996 Jul; 53(7):617-24. PubMed ID: 8929169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interest of anesthetic blocks for assessment of the spastic patient. A series of 815 motor blocks].
    Filipetti P; Decq P
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):226-38. PubMed ID: 12746697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial.
    Santamato A; Micello MF; Panza F; Fortunato F; Picelli A; Smania N; Logroscino G; Fiore P; Ranieri M
    Clin Rehabil; 2015 Jan; 29(1):50-8. PubMed ID: 24917588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological effects of botulinum toxin in spasticity.
    Gracies JM
    Mov Disord; 2004 Mar; 19 Suppl 8():S120-8. PubMed ID: 15027064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R; Akturk S; Ersoy Y
    Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.